Iqvia Holdings (IQV) Net Income towards Common Stockholders Growth (3y) (2015 - 2026)
Iqvia Holdings (IQV) Net Income towards Common Stockholders Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | 8.89% |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | -7.69% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | -6.41% |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | 14.66% |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | 2.87% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 10.22% |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn | 284.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.41% |
| Mar 31, 2026 | -2.59% |
| Dec 31, 2025 | 28.17% |
| Sep 30, 2025 | 4.61% |
| Jun 30, 2025 | 1.28% |
| Mar 31, 2025 | -7.31% |
| Dec 31, 2024 | 10.87% |
| Sep 30, 2024 | 2.86% |
| Jun 30, 2024 | 27.54% |
| Mar 31, 2024 | 10.96% |
| Dec 31, 2023 | 53.63% |
| Sep 30, 2023 | 41.58% |
| Jun 30, 2023 | 155.61% |
| Mar 31, 2023 | 50.72% |
| Dec 31, 2022 | 100.89% |
| Sep 30, 2022 | 60.61% |
| Jun 30, 2022 | 54.27% |
| Mar 31, 2022 | 69.13% |
| Dec 31, 2021 | 62.41% |
| Sep 30, 2021 | 58.94% |